Trinity Biotech reported $6.47M in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Abbott USD 6.65B 787M Jun/2026
Bayer EUR 8.17B 1.24B Mar/2026
Bio-Rad Laboratories USD 309.4M 35.8M Mar/2026
EDAP TMS EUR 8.15M 2.17M Mar/2026
J&J USD 18.55B 1.31B Jun/2026
Mesa Laboratories USD 39.75M 4.3M Dec/2024
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Roche Holding CHF 22.69B 600M Jun/2026
Siemens EUR 7.68B 51M Mar/2026
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tosoh JPY 67.57B 10.89B Sep/2025
Trinity Biotech USD 6.47M 1.59M Sep/2025
Veracyte USD 108.55M 7.39M Jun/2026